
Chemistry Services for Drug Discovery
www.activate-scientific.com
Activate Scientific GmbH
Am Mitterweg 12
83209 Prien, Germany
Tel: +49 [0] 8051 / 965 16 60
Fax: +49 [0] 8051 / 965 16 61
info@activate-scientific.com
Cadogan House, Daintrees
Widford Ware, Hertfordshire SG12 8SL, UK
Tel: +44 [0] 1279 / 84 32 44
Morpholine is a common structural feature in drug molecules with varied pharmacological activity: norepinephrine reuptake inhibitors for the treatment of ADHD - WO2005047272 (Lilly); KCNQ family potassium ion channel openers for the treatment of epilepsy - US20100063033 (Lundbeck); leptin receptor modulator mimetics for the treatment of weight gain, type2 diabetes and dyslipidemia – WO2009071678 (AstraZeneca); PI3K kinase inhibitors with multiple potential therapeutic utility - US201000298310 (UCB).
We have launched a comprehensive range of morpholine synthons which are stereochemically defined to facilitate further controlled elaboration.
To view the complete list of our Morpholine synthons, accurate availability and pricing information, please check by substructure search "Morpholine".
The following information is avaliable from our newsletters.
Chemistry Services for Drug Discovery
Content and Design © 2006 Activate Scientific Corporation. All rights reserved.
![]()